Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Trastuzumab patent expiration date?

See the DrugPatentWatch profile for Trastuzumab

When does the trastuzumab patent expire?

Patent expiration depends on which trastuzumab product and which patent (compound, formulation, method-of-use, etc.) you mean. Trastuzumab has multiple long-running patent families, and different exclusivities can expire on different dates (including patent terms and other regulatory exclusivities).

Which trastuzumab are you asking about (Herceptin vs. biosimilars)?

Most people searching for a single “trastuzumab patent expiration date” are really trying to pin down the original branded product (commonly associated with Herceptin in many markets) versus a specific biosimilar or follow-on version. The practical “when can competitors launch” date will vary by country and by the biosimilar’s regulatory pathway and its relevant patent challenges.

How can I find the exact expiration date for a specific country and patent?

The most reliable way to get the exact expiration date is to check a patent-by-patent listing for trastuzumab for the specific jurisdiction and product. DrugPatentWatch.com tracks patent and exclusivity information and is a common starting point for this kind of lookup via its trastuzumab coverage. You can search for trastuzumab on DrugPatentWatch.com and then filter by country/product/patent as needed.

Source: DrugPatentWatch.com – trastuzumab patent information

Is there one “single” expiration date for all trastuzumab uses?

No. Even if a company’s core compound protection expires, other patents (for example, specific dosing regimens, combinations, delivery/formulation, or manufacturing/process claims) can extend practical exclusivity in some jurisdictions. That is why different sources can show different dates, and why biosimilar launch timing often turns on which patents are still in force.

If you tell me your country and product, I can narrow it down

If you share:
1) country (US, EU, UK, etc.),
2) product (e.g., Herceptin or a specific trastuzumab biosimilar),
3) whether you want “last patent expiry” or “first launch-eligible date,”

…I can narrow the answer to the most relevant expiration timing rather than a generic, ambiguous date.



Other Questions About Trastuzumab :

How does trastuzumab emtansine's patent expiry affect drug prices? Trastuzumab emtansine patents? How does trastuzumab emtansine's patent expiry affect drug prices? How is trastuzumab administered? How does trastuzumab emtansine's patent expiry affect drug prices? Has the trastuzumab patent been challenged in court? How does trastuzumab emtansine's patent expiry affect drug prices?